Investors & Media

Transformative science, targeted medicines

Blueprint Medicines is a fully integrated global biopharmaceutical company that invents life-changing medicines across two strategic focus areas of allergy/inflammation and oncology/hematology. Our approach combines deep scientific expertise, modality-agnostic drug discovery capabilities, and a proven track record of R&D success. Currently, we are commercializing our approved medicine AYVAKIT/AYVAKYT® (avapritinib) in the U.S. and Europe, as well as in other regions of the world through partnerships.

Committee Composition

Committee Composition

Below is a summary of our committee structure and membership information. To read more about any of the committees, click on committee names in the chart below.
Audit Committee Compensation Committee Nominating and Corporate Governance Committee
Daniella Beckman Chairperson Audit Committee
Habib Dable Member Compensation Committee Member Nominating and Corporate Governance Committee
Lonnel Coats Member Audit Committee Chairperson Nominating and Corporate Governance Committee
Mark Goldberg, M.D. Member Audit Committee Member Compensation Committee
Lynn Seely, M.D. Financial Expert Chairperson Compensation Committee Member Nominating and Corporate Governance Committee
Chairperson Chairperson
Member Member
Financial Expert Lead Director
Chairperson Chairperson
Member Member
Financial Expert Lead Director